Kane LP - Search Results

1

Aberrant TGF-beta signaling reduces T regulatory cells in ICAM-1-deficient mice, increasing the inflammatory response to Mycobacterium tuberculosis.

Windish HP, Lin PL, Mattila JT, Green AM, Onuoha EO, Kane LP, Flynn JL. Windish HP, et al. Among authors: kane lp. J Leukoc Biol. 2009 Sep;86(3):713-25. doi: 10.1189/jlb.1208740. Epub 2009 May 19. J Leukoc Biol. 2009. PMID: 19454651 Free PMC article.

2

Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo.

Sasaki K, Zhao X, Pardee AD, Ueda R, Fujita M, Sehra S, Kaplan MH, Kane LP, Okada H, Storkus WJ. Sasaki K, et al. Among authors: kane lp. J Immunol. 2008 Jul 1;181(1):104-8. doi: 10.4049/jimmunol.181.1.104. J Immunol. 2008. PMID: 18566374 Free PMC article.

3

Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.

Turner MS, Kane LP, Morel PA. Turner MS, et al. Among authors: kane lp. J Immunol. 2009 Oct 15;183(8):4895-903. doi: 10.4049/jimmunol.0901459. J Immunol. 2009. PMID: 19801514 Free PMC article.

4

CARMA1 is required for Akt-mediated NF-kappaB activation in T cells.

Narayan P, Holt B, Tosti R, Kane LP. Narayan P, et al. Among authors: kane lp. Mol Cell Biol. 2006 Mar;26(6):2327-36. doi: 10.1128/MCB.26.6.2327-2336.2006. Mol Cell Biol. 2006. PMID: 16508008 Free PMC article.

5

T cell Ig and mucin domain-1-mediated T cell activation requires recruitment and activation of phosphoinositide 3-kinase.

de Souza AJ, Oak JS, Jordanhazy R, DeKruyff RH, Fruman DA, Kane LP. de Souza AJ, et al. Among authors: kane lp. J Immunol. 2008 May 15;180(10):6518-26. doi: 10.4049/jimmunol.180.10.6518. J Immunol. 2008. PMID: 18453570 Free PMC article.

6

Regulation of NF-κB induction by TCR/CD28.

Cheng J, Montecalvo A, Kane LP. Cheng J, et al. Among authors: kane lp. Immunol Res. 2011 Aug;50(2-3):113-7. doi: 10.1007/s12026-011-8216-z. Immunol Res. 2011. PMID: 21717079 Free PMC article. Review.

7

Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways.

Lee J, Su EW, Zhu C, Hainline S, Phuah J, Moroco JA, Smithgall TE, Kuchroo VK, Kane LP. Lee J, et al. Among authors: kane lp. Mol Cell Biol. 2011 Oct;31(19):3963-74. doi: 10.1128/MCB.05297-11. Epub 2011 Aug 1. Mol Cell Biol. 2011. PMID: 21807895 Free PMC article.

8

The duration of T cell stimulation is a critical determinant of cell fate and plasticity.

Miskov-Zivanov N, Turner MS, Kane LP, Morel PA, Faeder JR. Miskov-Zivanov N, et al. Among authors: kane lp. Sci Signal. 2013 Nov 5;6(300):ra97. doi: 10.1126/scisignal.2004217. Sci Signal. 2013. PMID: 24194584 Free PMC article.

9

Complement component C5a permits the coexistence of pathogenic Th17 cells and type I IFN in lupus.

Pawaria S, Ramani K, Maers K, Liu Y, Kane LP, Levesque MC, Biswas PS. Pawaria S, et al. Among authors: kane lp. J Immunol. 2014 Oct 1;193(7):3288-95. doi: 10.4049/jimmunol.1401322. Epub 2014 Aug 22. J Immunol. 2014. PMID: 25149466

10

Control of T lymphocyte fate decisions by PI3K signaling.

Murter B, Kane LP. Murter B, et al. Among authors: kane lp. F1000Res. 2020 Sep 25;9:F1000 Faculty Rev-1171. doi: 10.12688/f1000research.26928.1. eCollection 2020. F1000Res. 2020. PMID: 33024547 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page